Your browser doesn't support javascript.
loading
Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation.
Arranto, C A; Burkard, T; Leuppi-Taegtmeyer, A B; Gerull, S; Passweg, J R; Pfister, O; Halter, J P.
Afiliação
  • Arranto CA; Department of Hematology, University Hospital Basel, CH-4031, Basel, Switzerland. christian.arranto@usb.ch.
  • Burkard T; Hypertension Clinic, ESH Hypertension Centre of Excellence, Medical Outpatient Department, University Hospital Basel, CH-4031, Basel, Switzerland.
  • Leuppi-Taegtmeyer AB; Department of Clinical Pharmacology and Toxicology, University Hospital Basel, CH-4031, Basel, Switzerland.
  • Gerull S; Department of Hematology, University Hospital Basel, CH-4031, Basel, Switzerland.
  • Passweg JR; Department of Hematology, University Hospital Basel, CH-4031, Basel, Switzerland.
  • Pfister O; Department of Cardiology, University Hospital Basel, CH-4031, Basel, Switzerland.
  • Halter JP; Department of Hematology, University Hospital Basel, CH-4031, Basel, Switzerland.
Bone Marrow Transplant ; 56(1): 167-174, 2021 01.
Article em En | MEDLINE | ID: mdl-32665676
ABSTRACT
Cardiovascular risk factors (CVRF) are frequent among long-term survivors after allogeneic hematopoietic cell transplantation (HCT) but prospective data on CVRF are sparse. We conducted a cross-sectional single center study including patients who underwent a first HCT mostly for hematologic malignancies at our center between 2000 and 2016, surviving at least 1 year. 260 patients (median age 54 years [range 19-78], 40% female) who were median 6 years (range 1-16) after transplantation were included. Most patients (232, 89%) had peripheral blood stem cell transplantation. cGVHD was present in 41% at the time of study inclusion. Prevalence of hypertension, dyslipidemia, and diabetes was 58%, 63% and 9%, respectively. Untreated hypertension, dyslipidemia and diabetes was found in 15%, 35% and 2%. Among patients with treated hypertension, 38% did not have blood pressure controlled to levels ≤140/90 mmHg. 36% patients under lipid-lowering therapy did not reach their LDL target. Multivariable logistic regression analyses showed that age and diabetes increased the likelihood for hypertension and dyslipidemia, whereas body mass index, cGVHD and male sex predicted hypertension only. In summary, CVRF in long-term survivors are frequent and persisting after cessation of immunosuppression. A large proportion of CVRF are either untreated or uncontrolled.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article